JCM
GILD icon

Jacobsen Capital Management’s Gilead Sciences GILD Stock Holding History

Jacobsen Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Buy
1,997
+3
+0.2% +$395 0.07% 100
2026
Q1 		$278K Hold
1,994
– – 0.09% 87
2025
Q4 		$245K Sell
1,994
-22
-1% -$2.67K 0.08% 100
2025
Q3 		$224K Sell
2,016
-2
-0.1% -$227 0.08% 112
2025
Q2 		$224K Buy
+2,018
New +$215K 0.08% 102

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jacobsen Capital Management's GILD Position: Q2 2026 in Review

Jacobsen Capital Management increased its Gilead Sciences (GILD) stake by 0.15% in Q2 2026, buying an estimated $395 and bringing the position to 1,997 shares worth $252K. The position accounts for 0.07% of the portfolio, ranked #100.

Jacobsen Capital Management first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $278K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Jacobsen Capital Management held 1,997 shares of Gilead Sciences worth $252K as of Q2 2026.
  • Jacobsen Capital Management bought 3 Gilead Sciences shares in Q2 2026, an estimated $395.
  • Gilead Sciences made up 0.07% of Jacobsen Capital Management's portfolio in Q2 2026, its #100 holding.
  • Jacobsen Capital Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Jacobsen Capital Management's Gilead Sciences position peaked at $278K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Jacobsen Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.